Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.
Can a new light-based therapy help with Alzheimer’s disease?
Prof Michael R Hamblin of the Wellman Center for Photomedicine at Massachusetts General Hospital discusses a new light-based therapy for Alzheimer’s disease
Focusing on paediatric cancers
Epigenetic changes play a critical role in the development of paediatric cancers. Ivan Stamenkovic, Professor of Pathology, explains
Environmental chemicals: factors for neurodevelopmental disorders?
Pamela Lein, University of California, looks at whether environmental chemicals influence individual risk for the diagnosis of neurodevelopmental disorders
Adaptive clinical trials: Ethical and efficient
Prof Thomas Jaki at the Medical and Pharmaceutical Statistics Research Unit, Lancaster University outlines the benefits of adaptive clinical trials
Queueing theory: the solution to unsustainable wait list practices
David Stanford, Richard Boucherie, and Peter Taylor outline how queueing theory could help tackle some of the challenges in the healthcare sector
Can blueberries help to tackle many global health problems?
Mark Villata, Executive Director, U.S. Highbush Blueberry Council highlights many health benefits associated with blueberries
Innovation in the healthcare sector
France’s Ministry of Solidarity and Health say innovation in the healthcare sector is imperative and that decision makers must work to transform the system
Middle-aged people urged to be more active to stay healthy
Health officials are urging middle-aged people to be more active and incorporate at least 10- minutes of brisk exercise into their day to stay healthy
Progressing health research in the North of Canada
Health Sciences North Research Institute shares the progress it has made in health research in Northern Canada, highlighting some of its major focus areas
The burden of non-communicable diseases
The Swiss Federal Office of Public Health shares the strategies in place for non-communicable diseases and the importance evidence-based prevention policy
The PEGASO – Fit for Future project
Giuseppe Andreoni and Maria Renata Guarneri discuss how the PEGASO project is promoting sustainable behaviours geared towards achieving healthy lifestyles
All My Relations: advancing Indigenous family health
Dr Rod McCormick shares details on the All My Relations Network, a national Indigenous family and community wellness research centre for health and healing
Organ donation – where next?
Fiona Loud, Policy Director at Kidney Care UK highlights the challenges of organ donation in England and how the country lags behind Wales and Scotland
Illicit drugs know no borders, neither should policy making
Simone Korff de Gidts, The Netherlands Organisation for Health, Research and Development highlights the ERANID project for illicit drugs research
Health research, from molecules to patients, at DCU
Director of Research Support Dr Ana M Terres notes the importance of health research and the strides being achieved by researchers at Dublin City University
Mental health and medication: The importance of perspective
Peter Kinderman, from Mental Health Europe, looks at mental health medication and how we need a new perspective on care
New plans to reduce childhood obesity in the UK unveiled
An investment of £5 million has been announced by the Department of Health for a new childhood obesity policy research unit
The new unit at...
Gluten friendly technology fixes proteins in wheat kernels
Professor Carmen Lamacchia is the inventor of a new gluten friendly technology that promises to make bread and pasta safe for people with coeliac disease
Photodynamic Therapy – radiotherapy for the 21st Century
Photodynamic Therapy is a treatment that combines a photosensitizing drug, visible light and oxygen to kill cancer cells. Professor Eli Glatstein explains
Parkinson’s disease: are conventional treatments working?
Ramón Cacabelos, President of EuroEspes Biomedical Research Centre looks at conventional pharmacological treatments for Parkinson’s disease
